The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 19, 2019
Filed:
Aug. 04, 2017
Applicant:
Chemocentryx, Inc., Mountain View, CA (US);
Inventors:
Antoni Krasinski, Mountain View, CA (US);
Sreenivas Punna, Sunnyvale, CA (US);
Solomon Ungashe, Fremont, CA (US);
Qiang Wang, Union City, CA (US);
Yibin Zeng, San Mateo, CA (US);
Assignee:
ChemoCentryx, Inc., Mountain View, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); C07D 487/04 (2006.01); C07D 471/04 (2006.01); C07D 471/12 (2006.01); C07D 473/00 (2006.01); C07D 213/79 (2006.01); C07D 213/81 (2006.01); C07D 213/84 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); C07D 213/79 (2013.01); C07D 213/81 (2013.01); C07D 213/84 (2013.01); C07D 471/04 (2013.01); C07D 471/12 (2013.01); C07D 473/00 (2013.01);
Abstract
Compounds are provided that act as potent antagonists of the CCR2 receptor. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases and as controls in assays for the identification of CCR2 antagonists.